Παρασκευή 6 Ιανουαρίου 2017

New drugs, higher costs offer little survival benefit for American patients with advanced lung cancer

According to a University of Colorado Cancer Center study published in the Journal of Clinical Oncology, a decade that saw the development of new therapies for non-small cell lung cancer resulted in little survival benefit for patients with advanced-stage...

from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2jbu8X6
via IFTTT

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου

Δημοφιλείς αναρτήσεις